MILIBOO SA (ALMLB.PA) Fundamental Analysis & Valuation

EPA:ALMLB • FR0013053535

Current stock price

1.63 EUR
-0.03 (-1.81%)
Last:

This ALMLB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALMLB.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMLB has reported negative net income.
  • In the past year ALMLB has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALMLB reported negative net income in multiple years.
  • In multiple years ALMLB reported negative operating cash flow during the last 5 years.
ALMLB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMLB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M

1.2 Ratios

  • ALMLB has a Return On Assets of -1.63%. This is in the lower half of the industry: ALMLB underperforms 75.00% of its industry peers.
  • Looking at the Return On Equity, with a value of -4.04%, ALMLB is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -1.63%
ROE -4.04%
ROIC N/A
ROA(3y)0.93%
ROA(5y)2.07%
ROE(3y)-1.09%
ROE(5y)23.82%
ROIC(3y)N/A
ROIC(5y)N/A
ALMLB.PA Yearly ROA, ROE, ROICALMLB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

  • ALMLB's Gross Margin of 26.58% is on the low side compared to the rest of the industry. ALMLB is outperformed by 62.50% of its industry peers.
  • ALMLB's Gross Margin has been stable in the last couple of years.
  • ALMLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.16%
ALMLB.PA Yearly Profit, Operating, Gross MarginsALMLB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

4

2. ALMLB.PA Health Analysis

2.1 Basic Checks

  • ALMLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALMLB remains at a similar level compared to 1 year ago.
  • ALMLB has more shares outstanding than it did 5 years ago.
  • ALMLB has a better debt/assets ratio than last year.
ALMLB.PA Yearly Shares OutstandingALMLB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ALMLB.PA Yearly Total Debt VS Total AssetsALMLB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • ALMLB has an Altman-Z score of 3.38. This indicates that ALMLB is financially healthy and has little risk of bankruptcy at the moment.
  • ALMLB has a Altman-Z score of 3.38. This is amongst the best in the industry. ALMLB outperforms 81.25% of its industry peers.
  • ALMLB has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.10, ALMLB belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 3.38
ROIC/WACCN/A
WACC7.05%
ALMLB.PA Yearly LT Debt VS Equity VS FCFALMLB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

2.3 Liquidity

  • A Current Ratio of 1.62 indicates that ALMLB should not have too much problems paying its short term obligations.
  • ALMLB has a Current ratio of 1.62. This is comparable to the rest of the industry: ALMLB outperforms 53.13% of its industry peers.
  • ALMLB has a Quick Ratio of 1.62. This is a bad value and indicates that ALMLB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.50, ALMLB is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.5
ALMLB.PA Yearly Current Assets VS Current LiabilitesALMLB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

1

3. ALMLB.PA Growth Analysis

3.1 Past

  • The earnings per share for ALMLB have decreased strongly by -110.80% in the last year.
  • Looking at the last year, ALMLB shows a very negative growth in Revenue. The Revenue has decreased by -10.02% in the last year.
  • Measured over the past years, ALMLB shows a small growth in Revenue. The Revenue has been growing by 5.42% on average per year.
EPS 1Y (TTM)-110.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-210.5%
Revenue 1Y (TTM)-10.02%
Revenue growth 3Y-0.18%
Revenue growth 5Y5.42%
Sales Q2Q%6.83%

3.2 Future

  • Based on estimates for the next years, ALMLB will show a very negative growth in Earnings Per Share. The EPS will decrease by -31.83% on average per year.
  • ALMLB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.53% yearly.
EPS Next Y17.64%
EPS Next 2Y0.93%
EPS Next 3Y-31.83%
EPS Next 5YN/A
Revenue Next Year-8.57%
Revenue Next 2Y-6.23%
Revenue Next 3Y-8.53%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALMLB.PA Yearly Revenue VS EstimatesALMLB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M 50M
ALMLB.PA Yearly EPS VS EstimatesALMLB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 -0.2 0.3

4

4. ALMLB.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALMLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 6.04, the valuation of ALMLB can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, ALMLB is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
  • ALMLB is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.04
ALMLB.PA Price Earnings VS Forward Price EarningsALMLB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALMLB is valued a bit more expensive than the industry average as 68.75% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 136.92
ALMLB.PA Per share dataALMLB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • ALMLB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A cheap valuation may be justified as ALMLB's earnings are expected to decrease with -31.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.93%
EPS Next 3Y-31.83%

0

5. ALMLB.PA Dividend Analysis

5.1 Amount

  • ALMLB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALMLB.PA Fundamentals: All Metrics, Ratios and Statistics

MILIBOO SA

EPA:ALMLB (4/30/2026, 7:00:00 PM)

1.63

-0.03 (-1.81%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Industry Strength7.43
Industry Growth20
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.30M
Revenue(TTM)38.98M
Net Income(TTM)-257.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.04
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB 2.75
EV/EBITDA 136.92
EPS(TTM)-0.04
EYN/A
EPS(NY)0.27
Fwd EY16.56%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS5.62
BVpS0.92
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.63%
ROE -4.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.58%
FCFM N/A
ROA(3y)0.93%
ROA(5y)2.07%
ROE(3y)-1.09%
ROE(5y)23.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.16%
F-Score2
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 7.6
Cap/Depr 81%
Cap/Sales 1.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 0.5
Altman-Z 3.38
F-Score2
WACC7.05%
ROIC/WACCN/A
Cap/Depr(3y)200.54%
Cap/Depr(5y)208.68%
Cap/Sales(3y)2.1%
Cap/Sales(5y)2.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-210.5%
EPS Next Y17.64%
EPS Next 2Y0.93%
EPS Next 3Y-31.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.02%
Revenue growth 3Y-0.18%
Revenue growth 5Y5.42%
Sales Q2Q%6.83%
Revenue Next Year-8.57%
Revenue Next 2Y-6.23%
Revenue Next 3Y-8.53%
Revenue Next 5YN/A
EBIT growth 1Y-118.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.04%
EBIT Next 3Y-21.17%
EBIT Next 5YN/A
FCF growth 1Y-173.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-138.32%
OCF growth 3YN/A
OCF growth 5YN/A

MILIBOO SA / ALMLB.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMLB.PA.


What is the valuation status of MILIBOO SA (ALMLB.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to MILIBOO SA (ALMLB.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for MILIBOO SA?

MILIBOO SA (ALMLB.PA) has a profitability rating of 1 / 10.


Can you provide the financial health for ALMLB stock?

The financial health rating of MILIBOO SA (ALMLB.PA) is 4 / 10.


Can you provide the expected EPS growth for ALMLB stock?

The Earnings per Share (EPS) of MILIBOO SA (ALMLB.PA) is expected to grow by 17.64% in the next year.